123 related articles for article (PubMed ID: 33610608)
1. Utilization of a tetracycline-inducible system for high-level expression of recombinant proteins in Francisella tularensis LVS.
Sheshko V; Link M; Golovliov I; Balonova L; Stulik J
Plasmid; 2021 May; 115():102564. PubMed ID: 33610608
[TBL] [Abstract][Full Text] [Related]
2. TetR-based gene regulation systems for Francisella tularensis.
LoVullo ED; Miller CN; Pavelka MS; Kawula TH
Appl Environ Microbiol; 2012 Oct; 78(19):6883-9. PubMed ID: 22820330
[TBL] [Abstract][Full Text] [Related]
3. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a highly efficient Francisella shuttle plasmid.
Maier TM; Havig A; Casey M; Nano FE; Frank DW; Zahrt TC
Appl Environ Microbiol; 2004 Dec; 70(12):7511-9. PubMed ID: 15574954
[TBL] [Abstract][Full Text] [Related]
5. Development of novel plasmid vectors and a promoter trap system in Francisella tularensis compatible with the pFLN10 based plasmids.
Rasko DA; Esteban CD; Sperandio V
Plasmid; 2007 Sep; 58(2):159-66. PubMed ID: 17459476
[TBL] [Abstract][Full Text] [Related]
6. Construction of a bioluminescence reporter plasmid for Francisella tularensis.
Bina XR; Miller MA; Bina JE
Plasmid; 2010 Nov; 64(3):156-61. PubMed ID: 20620161
[TBL] [Abstract][Full Text] [Related]
7. Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis.
Kuoppa K; Forsberg A; Norqvist A
FEMS Microbiol Lett; 2001 Nov; 205(1):77-81. PubMed ID: 11728719
[TBL] [Abstract][Full Text] [Related]
8. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in
Cantlay S; Haggerty K; Horzempa J
J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588
[No Abstract] [Full Text] [Related]
9. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
10. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
11. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium, Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS).
Su S; Saldanha R; Pemberton A; Bangar H; Kawamoto SA; Aronow B; Hassett DJ; Lamkin TJ
Appl Microbiol Biotechnol; 2013 Oct; 97(20):9029-41. PubMed ID: 23852642
[TBL] [Abstract][Full Text] [Related]
12. Construction of a shuttle vector for use in Francisella tularensis.
Norqvist A; Kuoppa K; Sandström G
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):257-60. PubMed ID: 8861040
[TBL] [Abstract][Full Text] [Related]
13. Description of two new plasmids isolated from Francisella philomiragia strains and construction of shuttle vectors for the study of Francisella tularensis.
Le Pihive E; Blaha D; Chenavas S; Thibault F; Vidal D; Valade E
Plasmid; 2009 Nov; 62(3):147-57. PubMed ID: 19615403
[TBL] [Abstract][Full Text] [Related]
14. Improved shuttle vectors for Francisella tularensis genetics.
LoVullo ED; Sherrill LA; Pavelka MS
FEMS Microbiol Lett; 2009 Feb; 291(1):95-102. PubMed ID: 19067747
[TBL] [Abstract][Full Text] [Related]
15. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
16. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
[TBL] [Abstract][Full Text] [Related]
17. Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida.
Sarva ST; Waldo RH; Belland RJ; Klose KE
PLoS One; 2016; 11(8):e0158631. PubMed ID: 27537327
[TBL] [Abstract][Full Text] [Related]
18. A method for allelic replacement in Francisella tularensis.
Golovliov I; Sjöstedt A; Mokrievich A; Pavlov V
FEMS Microbiol Lett; 2003 May; 222(2):273-80. PubMed ID: 12770718
[TBL] [Abstract][Full Text] [Related]
19. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.
Horzempa J; Carlson PE; O'Dee DM; Shanks RM; Nau GJ
BMC Microbiol; 2008 Oct; 8():172. PubMed ID: 18842136
[TBL] [Abstract][Full Text] [Related]
20. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
